NEW YORK, July 18, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Onconetix, Inc. (NASDAQ: ONCO)'s merger with Ocuvex Therapeutics, Inc. Upon completion of the proposed transaction, Onconetix shareholders will own 10% of the combined company. If you are an Onconetix shareholder, click here to learn more about your rights and options.
Waters Corporation (NYSE: WAT)'s merger with BD and Company's Biosciences & Diagnostic Solutions business. Upon completion of the proposed transaction, existing Waters shareholders are expected to own approximately 60.8% of the combined company. If you are a Waters shareholder, click here to learn more about your rights and options.
Longevity Health Holdings, Inc. (NASDAQ: XAGE)'s merger with 20/20 BioLabs, Inc. Upon closing of the proposed transaction, Longevity shareholders are expected to own approximately 49.9% of the combined company. If you are a Longevity shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders. We would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-onco-wat-xage-on-behalf-of-shareholders-302508665.html
SOURCE Halper Sadeh LLP
